Glaucia Paranhos-Baccala

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Biomerieux, Inc., Centre National De La Recherche Scientifique, Other. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glaucia Paranhos-Baccala. Retrieved from https://idiyas.com/inventor/glaucia-paranhos-baccala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 68.8

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 35(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

1 out of 834,570

Other

patents

Years Active: 1998-2019

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10465012 - Bioresorbable nonlamellar microparticles and uses thereof (2019-11-05),

2. 8377477 - Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof (2013-02-19),

3. 8088910 - Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region (2012-01-03),

4. 7932350 - Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes (2011-04-26),

5. 7771927 - Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region (2010-08-10),

6. 7674888 - Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes (2010-03-09),

7. 7632931 - Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent (2009-12-15),

8. 7381817 - LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus (2008-06-03),

9. 6933110 - Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease (2005-08-23),

10. 6582703 - Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting (2003-06-24),

11. 6579526 - Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes (2003-06-17),

12. 6548295 - Complex of lipo-viro-particles, method of preparation and applications (2003-04-15),

13. 6403103 - Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease (2002-06-11),

14. 6270767 - Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease (2001-08-07),

15. 6001987 - Isolated nucleotide sequences associated with Multiple sclerosis (1999-12-14),

Title: Glaucia Paranhos-Baccala: Innovator in Bioresorbable Microparticles

Introduction

Glaucia Paranhos-Baccala is a prominent inventor based in Lyons, France. She has made significant contributions to the field of bioresorbable microparticles, holding a total of 16 patents. Her innovative work focuses on the development of nonlamellar microparticles that have various applications in medical diagnosis and therapy.

Latest Patents

Among her latest patents are "Bioresorbable nonlamellar microparticles and uses thereof" and "Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof." The first patent describes a method for preparing nonlamellar bioresorbable microparticles to which protein substances are bonded. This process involves preparing the microparticles from at least one bioresorbable polymer without stabilizer and surfactant, followed by bonding protein substances to the microparticles without surfactant. The second patent outlines a method for producing these microparticles and their applications in diagnosis and therapy.

Career Highlights

Glaucia has worked with notable organizations such as bioMérieux, Inc. and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Throughout her career, Glaucia has collaborated with esteemed colleagues, including Florence Komurian-Pradel and Herve Perron. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Glaucia Paranhos-Baccala is a trailblazer in the field of bioresorbable microparticles, with a strong portfolio of patents that reflect her innovative spirit. Her contributions to medical technology continue to pave the way for advancements in diagnosis and therapy.

Profile summary based on public USPTO records.